Testosterone replacement for older men with sarcopenia

Trial Profile

Testosterone replacement for older men with sarcopenia

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 01 Mar 2017

At a glance

  • Drugs Testosterone (Primary)
  • Indications Hypogonadism
  • Focus Therapeutic Use
  • Acronyms TOM
  • Most Recent Events

    • 22 Feb 2017 Status changed from completed to discontinued because of higher incidence of cardiovascular events in the testosterone arm of the trial.
    • 07 Jun 2011 Results presented at the 93rd Annual Meeting of the Endocrine Society.
    • 30 Jun 2010 Tolerability results published in the New England Journal of Medicine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top